Atsuya Nakamura

Title: Atsuya Nakamura: Innovator in Pharmaceutical Formulations

Introduction

Atsuya Nakamura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative oral administration methods. With a total of 2 patents to his name, Nakamura's work focuses on enhancing the solubility and absorbability of critical medications.

Latest Patents

Nakamura's latest patents include a suspension for oral administration comprising amorphous tolvaptan. This invention provides a suspension that contains particles of amorphous tolvaptan, which can inhibit or delay crystallization over time. This formulation stably maintains high solubility and excellent absorbability from the gastrointestinal tract. Additionally, he has developed a solid formulation for oral administration that can be suspended for use. Another notable patent is a solid dispersion comprising amorphous cilostazol, which retains cilostazol in an amorphous state in the gastrointestinal tract for a certain period after oral administration.

Career Highlights

Atsuya Nakamura is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the delivery methods of various medications, ensuring better patient outcomes.

Collaborations

Nakamura has collaborated with notable colleagues, including Akitsuna Akagi and Kai Suzuki, to further enhance the research and development of pharmaceutical products.

Conclusion

Atsuya Nakamura's contributions to pharmaceutical formulations demonstrate his commitment to improving medication delivery systems. His innovative patents reflect a deep understanding of the complexities involved in drug solubility and absorbability.